Cardinal Health Q3 revenue +13% to $50.5B; raises FY23 non-GAAP EPS guidance to $5.60-$5.80

CARDINAL HEALTH INC

2024-FY EPS reported $1.41 revenue$151,559,000,000

Revenue $50.5B (+13% YoY); GAAP EPS $1.34 (vs -$5.05 loss); Non-GAAP EPS $1.74 (+20% YoY).
Pharmaceutical segment profit $600M (+23%); Medical segment profit $20M (-66%).
FY23 non-GAAP EPS guidance raised to $5.60-$5.80 from $5.20-$5.50; adjusted FCF raised to $2.0-$2.3B.
Cooperation agreement with Elliott extended to July 15, 2024; Business Review Committee extended similarly.
Pharmaceutical profit growth outlook raised to 10.5%-12%; Medical profit outlook lowered to ~50% decline.

item 1.01 item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CARDINAL HEALTH INC reported third quarter fiscal year 2023 (quarter ended March 31, 2023) results: revenue $50.5 billion, net income $345 million, EPS $1.34. Guidance raised.

Period: third quarter fiscal year 2023 (quarter ended March 31, 2023)
Revenue: $50.5 billion
Net income: $345 million
EPS: $1.34
Guidance: raised
Result: reported results

Exact text from the filing

Today reported third quarter fiscal year 2023 revenues of $50.5 billion, an increase of 13% from the third quarter of fiscal year 2022. Third quarter GAAP operating earnings were $572 million and GAAP diluted earnings per share (EPS) were $1.34.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

CARDINAL HEALTH INC amended First Amendment with Elliott Associates, L.P., Elliott International, L.P., Elliott International Capital Advisors Inc. (effective 2023-05-03).

Action: amendment
Counterparty: Elliott Associates, L.P., Elliott International, L.P., Elliott International Capital Advisors Inc.
Effective: 2023-05-03

Exact text from the filing

On May 3, 2023, Cardinal Health, Inc., (the “Company”) entered into a First Amendment (the “Amendment”) to the Cooperation Agreement (the “Cooperation Agreement”) dated September 5, 2022 by and among Elliott Associates, L.P., Elliott International, L.P. and Elliott International Capital Advisors Inc. and the Company.

View on SEC.gov

Browse all earnings releases →

CARDINAL HEALTH INC filing history →

Source: SEC EDGAR

accession 0001193125-23-135011

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.